Hydrochloric Acid → (3S)-3-({4-[2-fluoro-4-(7-quinolinyl)phenyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}methyl)-N,N-dimethyl-1-pyrrolidinecarboxamide

HRID 525253노트

반응식

HRID 525253 반응식
[F:1][C:2]1[CH:7]=[C:6]([C:8]2[CH:17]=[C:16]3[C:11]([CH:12]=[CH:13][CH:14]=[N:15]3)=[CH:10][CH:9]=2)[CH:5]=[CH:4][C:3]=1[N:18]1[C:22](=[O:23])[NH:21][N:20]=[C:19]1[CH2:24][C@@H:25]1[CH2:29][CH2:28][N:27]([C:30]([O:32]C(C)(C)C)=O)[CH2:26]1.Cl.[CH:38]([N:41](CC)[CH:42](C)C)(C)C.CNN(NC)C(Cl)=O.[NH4+].[Cl-]>O1CCOCC1.ClCCl>[F:1][C:2]1[CH:7]=[C:6]([C:8]2[CH:17]=[C:16]3[C:11]([CH:12]=[CH:13][CH:14]=[N:15]3)=[CH:10][CH:9]=2)[CH:5]=[CH:4][C:3]=1[N:18]1[C:22](=[O:23])[NH:21][N:20]=[C:19]1[CH2:24][C@@H:25]1[CH2:29][CH2:28][N:27]([C:30]([N:41]([CH3:42])[CH3:38])=[O:32])[CH2:26]1

참가 물질

8

실험 절차

Into a 8 mL screwcap vial was placed 1,1-dimethylethyl (3S)-3-({4-[2-fluoro-4-(7-quinolinyl)phenyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}-methyl)-1-pyrrolidinecarboxylate (0.161 mmol). Added to the vial was 4N HCl in dioxane (1 mL). The reaction mixture was capped and stirred at room temperature for 2 h. The solution was concentrated in vacuo. Added to the vial were dichloromethane (1 mL) and N,N-diisopropylethylamine (0.573 mmol). In a separate vial, N,N-dimethylaminocarbamoyl chloride (0.161 mmol) was dissolved in 1 mL dichloromethane and added to the starting material dropwise via pipette. The vial was capped and the reaction was stirred at room temperature for 2 h. An extra 2 mL dichloromethane was added to the vial, followed by the addition of saturated aq NH4Cl (2 mL). The vial was capped and lightly agitated for 1 min. The organic layer was separated, filtered through a plug of sodium sulfate, and concentrated in vacuo. Reverse phase HPLC (10-65% acetonitrile/water+0.1% NH4OH) was utilized in purifying the title compound (44 mg, 59%). MS(ES)+ m/e 461.2 [M+H]+.

후처리

  1. additionAdded to the vial
  2. customThe reaction mixture was capped
  3. concentrationThe solution was concentrated in vacuo
  4. additionAdded to the
  5. additionadded to the starting material dropwise via pipette
  6. customThe vial was capped
  7. stirringthe reaction was stirred at room temperature for 2 h
  8. customThe vial was capped
  9. stirringlightly agitated for 1 min
  10. customThe organic layer was separated
  11. filtrationfiltered through a plug of sodium sulfate
  12. concentrationconcentrated in vacuo
  13. customin purifying the title compound (44 mg, 59%)

출처 및 근거

ORD 기록
ord-ca44d6b7f89c451ba463d85a60a4aeeb
출처 데이터셋
uspto-grants-2016_05
특허 번호
US09340529B2

반응 노트

불러오는 중…